Medical,economical and social risk of counterfeit drugs

dc.contributor.advisorVáradi, Judit
dc.contributor.advisordeptDepartment of pharmaceutical technologyhu_HU
dc.contributor.authorRina, Daniel
dc.contributor.departmentDE--Gyógyszerésztudományi Karhu_HU
dc.contributor.opponentBenkő, Szilvia
dc.contributor.opponentTóth, Béla
dc.contributor.opponentdeptDebreceni Egyetem::Gyógyszerésztudományi Karhu_HU
dc.date.accessioned2018-05-24T09:38:21Z
dc.date.available2018-05-24T09:38:21Z
dc.date.created2018-05-24
dc.description.abstractPharmaceuticals are pivotal for the health and well-being of populations. Their consumption and access can be related to a double-edged sword: on one hand, they ease the manifestation of disease but on the other hand, if they are inappropriately used, or worse are counterfeit or sub-standard, they may be ineffective and even harmful to the individuals who take them. For such reasons, it is necessary for countries to heed to the highest standards of quality in the manufacture, regulation, and distribution of drugs. Counterfeiting of medicine is a challenging worldwide issue that involves manufacture and distribution of pharmaceuticals, which is part of industrialized organized crime. The huge profits made and the complexity of the market is the other main reason for the growth of this enterprise. To prevent and reduce the growth of counterfeiting, international cooperation is needed and the contribution of the health care professionals.hu_HU
dc.description.correctorgj
dc.description.coursegyógyszerészhu_HU
dc.description.courselangangolhu_HU
dc.description.degreeMSc/MAhu_HU
dc.format.extent32hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/252716
dc.language.isoenhu_HU
dc.subjectcounterfeit drugshu_HU
dc.subject.dspaceDEENK Témalista::Orvostudományhu_HU
dc.titleMedical,economical and social risk of counterfeit drugshu_HU
Fájlok